Lactate dehydrogenase as a tumour marker in adult Wilm's tumour

British Journal of Urology

Volumn 80, Issue 4, 1997, Pages 670-671

  Pandian, S S ^a   Mcclinton, S ^a,b   Bissett, D ^a,b   Ewen, S W B ^a  

^a NHS GRAMPIAN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; DOXORUBICIN; LACTATE DEHYDROGENASE; TUMOR MARKER; VINCRISTINE;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CASE REPORT; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; NEPHROBLASTOMA; PATIENT MONITORING; PRIORITY JOURNAL;

EID: 0031400334     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1997.00312.x     Document Type: Article

References (3)

1. Williams G, Colbeck RA, Gowing NF. Adult Wilm's tumour: review of 14 patients. Br J Urol 1992; 70: 230-5
2. Liubimova NV. The significance of changes in LDH activity for the diagnosis and effective treatment of nephroblastoma in children. Voprosy Onkologii 1994; 40: 319-22
3. Carl J, Christensen TB, van der Maase H. Cisplatinum dose dependent response in germ cell cancer evaluated by tumour marker modelling. Acta Oncologica 1992; 31: 749-53